“Taking these medications puts individuals at risk of everything from allergic reactions to uncontrolled blood sugar levels, ...

The millennial-targeted telehealth company Hims & Hers (HIMS) is spending big bucks on its first ever Super Bowl commercial ...

Danish drugmaker Novo Nordisk reported fourth quarter and full year 2024 earnings Wednesday, beating Wall Street's ...

Telehealth company Hims & Hers' first Super Bowl ad is provocative and effective in building awareness of its weight loss ...

Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?

While popular drugs like Ozempic and Wegovy are only available as injections, drugmaker Novo Nordisk is working on a more ...

Sales of Wegovy, a prescription weight loss injection, surged to 19.9 billion Danish kroner (£2.2 billion) in the fourth quarter of last year.

The drugs, which include Mounjaro, Ozempic and Wegovy, have ushered in a new era ... over 350,000 patients — have now discovered the injections put users at 'significantly higher' risk of ...

Fresh questions are being asked about the use of weight loss injections after pharmacists ... size emerged , compared to the "gorilla" of Wegovy. The two biggest selling GLP-1 drugs are branded ...